Robeco Institutional Asset Management B.V. Supernus Pharmaceuticals, Inc. Transaction History
Robeco Institutional Asset Management B.V.
- $50.6 Billion
- Q1 2025
A detailed history of Robeco Institutional Asset Management B.V. transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 8,151 shares of SUPN stock, worth $264,744. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,151Holding current value
$264,744% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SUPN
# of Institutions
300Shares Held
60.5MCall Options Held
22.3KPut Options Held
6K-
Black Rock Inc. New York, NY10.4MShares$338 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.15MShares$200 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.84MShares$157 Million2.47% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$93.5 Million0.03% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$85.4 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.74B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...